HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

trimebutine 3-thiocarbamoylbenzenesulfonate

Analgesics; structure in first source

Also Known As:

GIC-1001

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzenesulfonates
        trimebutine 3-thiocarbamoylbenzenesulfonate: 2
- Sulfur Compounds: 278
  - Sulfur Acids
    - Sulfonic Acids: 1605
      - Arylsulfonic Acids
        Arylsulfonates: 1
        Benzenesulfonates
        trimebutine 3-thiocarbamoylbenzenesulfonate: 2

Experts

1.	Castro, M: 1 article (05/2016)
2.	Cenac, N: 1 article (05/2016)
3.	Colin, P: 1 article (05/2016)
4.	Desormeaux, C: 1 article (05/2016)
5.	Ranger, M: 1 article (05/2016)
6.	Sie, M: 1 article (05/2016)
7.	Vergnolle, N: 1 article (05/2016)
8.	Colin, Patrick: 1 article (11/2014)
9.	Iovu Niculita, Mirela: 1 article (11/2014)
10.	Lefebvre, Marc: 1 article (11/2014)

Related Diseases

1.

11/01/2014 - "Trimebutine 3-thiocarbamoylbenzenesulfonate (GIC-1001) is a new drug intended to be used for the management of visceral pain in patients undergoing sedation-free, full colonoscopy. "
05/01/2016 - "Taken together, these results demonstrated increased antinociceptive properties for GIC-1001 compared to trimebutine, suggesting that this compound would be a better option to relieve from visceral pain and discomfort induced by lumenal distension."

Related Drugs and Biologics

1.	Trimebutine